Know what deserves attention before opening another dashboard.

Priority is rule-based. Direct recent negative filings, critical cross-confirmed counter-signals and catalyst contradictions rank ahead of broader evidence clusters and positive catalysts awaiting proof. Queue priority measures review urgency, not investment risk, expected return, price impact or action. Missing evidence is never treated as a pass.